BackgroundBreast cancer is the most common cancer affecting women in Morocco. Screening for early detection has led to reduction in mortality from the disease. It is known that female healthcare professionals have greater influence on women's positive perception of breast cancer and motivation to practice screening methods for early detection of the disease. This study aims to investigate knowledge of breast cancer risk factors, beliefs about treatment and practice of screening methods among a cohort of female healthcare professionals in Morocco.MethodsA cross-sectional study was conducted using a self-administered questionnaire to assess the knowledge of breast cancer risk factors, beliefs about treatment and practice of screening methods among 136 female doctors and nurses working in the university hospital of Rabat, Morocco. Stratified random sampling method was employed. Chi square test, analysis of variance and Mantel-Haenszel test were performed in data analysis using SPSS v19.0.ResultsFemale doctors were the only professional group that had satisfactory knowledge of risk factors while the nurses had an unsatisfactory knowledge with a mean score of 43%. A half of participants believed that that herbal therapy can cure breast cancer. 75% practice breast self-examination once a month and only 15% have ever had a mammogram. Age, profession and beliefs were not significantly associated with rate of BSE in this study; however this rate is influenced by knowledge of breast cancer risk factors.ConclusionResults from this study suggest the need for continuing medical education programs aimed at improving knowledge of breast cancer among the nurses.
Introduction Primary laryngeal lymphomas are exceedingly rare. Only about a hundred cases have been reported. They consist mainly of non-Hodgkin lymphoma, especially of diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue. We report the first case of a primary laryngeal mantle cell lymphoma. Case presentation We report a case of a primary mantle cell lymphoma of the larynx in a 70-year-old North African non-smoker male. We present a detailed report of his clinical and paraclinical data as well as treatment options. Conclusions Mantle cell lymphoma is a very aggressive lymphoma subset associated with poor prognosis. Laryngeal mantle cell lymphoma is exceedingly rare. To the best of our knowledge, this is the first case to ever be reported.
Le carcinosarcome du sein souvent appelé carcinome métaplasique du sein, est une tumeur maligne rare composée de deux lignées cellulaires distinctes, il est décrit comme un cancer du sein de type canalaire avec un composant de type sarcome. Il représente 0,08-0.2% de toutes les tumeurs malignes du sein. Il s'agit d'une étude rétrospective étalée sur un an, huit cas des carcinosarcomes mammaires ont été colligés à l'Institut national d'oncologie au Maroc durant l'année 2007. La médiane d’âge était de 49,5 ans, toutes les tumeurs étaient de haut grade, cliniquement 5 cas ont été classé t2 ou t3, et 3 cas classé sein localement avancé. Le traitement envisagé était basé sur une chirurgie mammaire suivie d'une radiothérapie et d'une chimiothérapie pour les cas adjuvants, l'envahissement ganglionnaire a été noté dans un cas, les récepteurs œstrogèniques sont négatifs, alors que les récepteurs progesteroniques sont positifs dans 4 cas, l'expression d'Her2 est absente dans tous les cas, le traitement des carcinosarcomes mammaires métastatiques était basé sur une chimiothérapie palliative. A 20 mois de médiane follow-up, la survie sans progression(SSP) pour le groupe entier est de 62,5%. Dans la limite de ce suivi, une rechute locorégionale a été détectée dans un cas, les deux patientes métastatiques sont décédées. Le carcinosarcome du sein est un sous-type rare du cancer du sein qui a un profil particulier et agressif, il a souvent un caractère triple négatif. Il est nécessaire de développer d'autres voies de recherche comme cibler le Récepteur HER1/EGFR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.